MPLT Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
MapLight Therapeutics Inc (MPLT) is not a strong buy at the moment for a beginner, long-term investor with $50,000-$100,000 to invest. The lack of positive financial growth, absence of significant trading trends, no recent news or catalysts, and neutral technical indicators suggest it is better to hold off on purchasing this stock right now.
The technical indicators are neutral to slightly bullish. The MACD is positive but contracting, RSI is neutral at 65.157, and moving averages are bullish (SMA_5 > SMA_20 > SMA_200). The stock is trading near its resistance level of 19.82, with a pivot at 18.422. However, there is no strong signal for a breakout or significant upward momentum.
No recent news, no significant hedge fund or insider activity, and no congress trading data available. Technical indicators show slight bullishness but no strong upward momentum.
The company has shown no financial growth in its latest quarter (2024/Q2), with revenue, net income, EPS, and gross margin all stagnant at 0% YoY change. Additionally, the stock trend analysis suggests a potential minor decline in the short term (-1.69% next day, -1.04% next week).
In 2024/Q2, the company reported no revenue growth (0% YoY), a net income of -18.4M, and an EPS of -1.26, all showing no improvement from the previous year. Gross margin remains at 0%.
No recent analyst ratings or price target changes are available.
